Evidence map›Paper›PMID 39437550›Full record

ArticleBlood2025

Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression.

Tianyi Zhang, Yi-Fang Wang, Alex Montoya, Ilinca Patrascan, Nehir Nebioglu, Husayn A Pallikonda, Radina Georgieva, James W D King, Holger B Kramer, Pavel V Shliaha and 2 more

Abstract read
In one paragraph

Article in Blood, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Genetic susceptibility ofGlobal medical genetics · 2025
    Article
  8. Article
  9. Article
  10. IKZF-associated inborn errors of immunity.Journal of human immunity · 2025
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tianyi ZhangMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0003-1201-9748
Yi-Fang WangMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.
Alex MontoyaMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.
Ilinca PatrascanMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0003-2740-6767
Nehir NebiogluMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0002-4357-056X
Husayn A PallikondaMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0003-4472-2067
Radina GeorgievaMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0002-2241-2175
James W D KingMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0009-0009-7847-6475
Holger B KramerMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.
Pavel V ShliahaMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0003-3092-0724
David S RuedaMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0003-4657-6323
Matthias MerkenschlagerMedical Research Council Laboratory of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0003-2889-3288

Funding

Medical Research Council MC_U120027516Medical Research Council MC_UP_1102/5Wellcome Trust 099276Wellcome Trust 215933
6 · The paper itself

Abstract

abstractThe transcription factor (TF) Ikaros zinc finger 1 (IKZF1) is essential for B-cell development, and recurrently mutated in human B-cell acute lymphoblastic leukemia (B-ALL). IKZF1 has been ascribed both activating and repressive functions via interactions with coactivator and corepressor complexes, but the relative abundance of IKZF1-associated coregulators and their contribution to IKZF1-mediated gene regulation are not well understood. To address this, we performed an unbiased identification of IKZF1-interacting proteins in pre-B cells and found that IKZF1 interacts overwhelmingly with corepressors and heterochromatin-associated proteins. Time-resolved analysis of transcription and chromatin state identified transcriptional repression as the immediate response to IKZF1 induction. Transcriptional repression preceded transcriptional activation by several hours, manifesting as a decrease in the fraction of transcriptional bursts at the single-molecule level. Repression was accompanied by a rapid loss of chromatin accessibility and reduced levels of histone H3 lysine 27 acetylation (H3K27ac), particularly at enhancers. We identified highly conserved helical motifs within the intrinsically disordered region of IKZF1 that mediate its association with the nucleosome remodeling and deacetylase (NuRD) corepressor complex through critical "KRK" residues that bind the NuRD subunit retinoblastoma binding protein 4 (RBBP4), a mechanism shared with the TFs FOG1, BCL11A, and SALL4. Functional characterization reveals that this region is necessary for the efficient silencing of target genes and antiproliferative functions of IKZF1 in B-ALL.

Indexed as

Ikaros Transcription FactorMi-2 Nucleosome Remodeling and Deacetylase ComplexTranscription, GeneticAmino Acid MotifsConserved SequenceHumansPrecursor B-Cell Lymphoblastic Leukemia-LymphomaProtein BindingIkaros Transcription FactorIKZF1 protein, humanMi-2 Nucleosome Remodeling and Deacetylase Complex

Identifiers

PMID39437550
PMCPMC7617475

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.